Dr. Jaiswal is an assistant professor at Stanford University in the Department of Pathology and Institute for Stem Cell Biology and Regenerative Medicine, where his lab focuses on understanding the biology of the aging blood system. Several years ago, he identified a common, pre-malignant state for blood cancers, termed "clonal hematopoiesis”, by analyzing large human genome sequencing studies. He discovered that clonal hematopoiesis is prevalent in the aging population and increases the risk of not only blood cancers, but also cardiovascular disease and overall mortality. Understanding the biology of these mutations and how they contribute to the development of cancer and other age-related diseases is the current focus of work in the lab. Ultimately, Dr. Jaiswal and his team aim to develop novel therapies that can prevent adverse outcomes due to clonal hematopoiesis.